Sapience Therapeutics, Inc.

2 Overhill Road
Suite 400
Scarsdale
New York
10583
United States

Show jobs for this employer

About Sapience Therapeutics, Inc.

Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme (GBM), which is the most severe and deadly form of brain cancer.
YEAR FOUNDED
December 2015
LEADERSHIP:
CEO: Barry Kappel, Ph.D., MBA
Chairman: Howard Pien
CLINICAL TRIAL:
Please click here for clinical trial information.

8 articles with Sapience Therapeutics, Inc.